Literature DB >> 35644283

Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner.

Wei Wang1, Luciane M Silva1, Henry H Wang1, Matthew A Kavanaugh1, Tana S Pottorf1, Bailey A Allard1, Damon T Jacobs1, Rouchen Dong1, Joseph T Cornelius1, Aakriti Chaturvedi1, Katherine I Swenson-Fields1, Timothy A Fields2, Michele T Pritchard3, Madhulika Sharma4, Chad Slawson5, Darren P Wallace4, James P Calvet5, Pamela V Tran6.   

Abstract

Primary cilia are sensory organelles built and maintained by intraflagellar transport (IFT) multiprotein complexes. Deletion of several IFT-B genes attenuates polycystic kidney disease (PKD) severity in juvenile and adult autosomal dominant polycystic kidney disease (ADPKD) mouse models. However, deletion of an IFT-A adaptor, Tulp3, attenuates PKD severity in adult mice only. These studies indicate that dysfunction of specific cilia components has potential therapeutic value. To broaden our understanding of cilia dysfunction and its therapeutic potential, we investigate the role of global deletion of an IFT-A gene, Ttc21b, in juvenile and adult mouse models of ADPKD. Both juvenile (postnatal day 21) and adult (six months of age) ADPKD mice exhibited kidney cysts, increased kidney weight/body weight ratios, lengthened kidney cilia, inflammation, and increased levels of the nutrient sensor, O-linked β-N-acetylglucosamine (O-GlcNAc). Deletion of Ttc21b in juvenile ADPKD mice reduced cortical collecting duct cystogenesis and kidney weight/body weight ratios, increased proximal tubular and glomerular dilations, but did not reduce cilia length, inflammation, nor O-GlcNAc levels. In contrast, Ttc21b deletion in adult ADPKD mice markedly attenuated kidney cystogenesis and reduced cilia length, inflammation, and O-GlcNAc levels. Thus, unlike IFT-B, the effect of Ttc21b deletion in mouse models of ADPKD is development-specific. Unlike an IFT-A adaptor, deleting Ttc21b in juvenile ADPKD mice is partially ameliorative. Thus, our studies suggest that different microenvironmental factors, found in distinct nephron segments and in developing versus mature stages, modify ciliary homeostasis and ADPKD pathobiology. Further, elevated levels of O-GlcNAc, which regulates cellular metabolism and ciliogenesis, may be a pathological feature of ADPKD.
Copyright © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IFT139; Thm1; ciliopathy; early onset; late onset; renal cystic disease

Mesh:

Substances:

Year:  2022        PMID: 35644283      PMCID: PMC9398994          DOI: 10.1016/j.kint.2022.04.034

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   18.998


  74 in total

1.  Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.

Authors:  Benjamin S Freedman; Albert Q Lam; Jamie L Sundsbak; Rossella Iatrino; Xuefeng Su; Sarah J Koon; Maoqing Wu; Laurence Daheron; Peter C Harris; Jing Zhou; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

2.  Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function.

Authors:  Ee Phie Tan; Maria T Villar; Lezi E; Jianghua Lu; J Eva Selfridge; Antonio Artigues; Russell H Swerdlow; Chad Slawson
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

3.  Analysis of primary cilia in renal tissue and cells.

Authors:  Luciane M Silva; Wei Wang; Bailey A Allard; Tana S Pottorf; Damon T Jacobs; Pamela V Tran
Journal:  Methods Cell Biol       Date:  2019-05-17       Impact factor: 1.441

4.  TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote trafficking of G protein-coupled receptors into primary cilia.

Authors:  Saikat Mukhopadhyay; Xiaohui Wen; Ben Chih; Christopher D Nelson; William S Lane; Suzie J Scales; Peter K Jackson
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 5.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.

Authors:  Gerald W Hart; Chad Slawson; Genaro Ramirez-Correa; Olof Lagerlof
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

6.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

7.  O-GlcNAcylation of RAF1 increases its stabilization and induces the renal fibrosis.

Authors:  Du Feng; Li Sheng-Dong; Wu Tong; Du Zhen-Xian
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-09-12       Impact factor: 5.187

8.  Polycystin-2 is an essential ion channel subunit in the primary cilium of the renal collecting duct epithelium.

Authors:  Xiaowen Liu; Paul G DeCaen; Thuy Vien; Jingjing Duan; Shu-Hsien Sheu; David E Clapham
Journal:  Elife       Date:  2018-02-14       Impact factor: 8.140

9.  Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.

Authors:  Ming Ma; Xin Tian; Peter Igarashi; Gregory J Pazour; Stefan Somlo
Journal:  Nat Genet       Date:  2013-07-28       Impact factor: 38.330

10.  Loss of polycystins suppresses deciliation via the activation of the centrosomal integrity pathway.

Authors:  Vasileios Gerakopoulos; Peter Ngo; Leonidas Tsiokas
Journal:  Life Sci Alliance       Date:  2020-07-10
View more
  2 in total

Review 1.  Cilia-Localized Counterregulatory Signals as Drivers of Renal Cystogenesis.

Authors:  Rebecca V Walker; Anthony Maranto; Vivek Reddy Palicharla; Sun-Hee Hwang; Saikat Mukhopadhyay; Feng Qian
Journal:  Front Mol Biosci       Date:  2022-06-23

Review 2.  O-GlcNAcylation in Renal (Patho)Physiology.

Authors:  Rodrigo P Silva-Aguiar; Diogo B Peruchetti; Ana Acacia S Pinheiro; Celso Caruso-Neves; Wagner B Dias
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.